Files and links (1)
Published, Version of Record (VoR)CC BY-NC-ND V4.0, Open
Journal article
Sulfoxythiocarbamate S-4 inhibits HSP90 in human cutaneous squamous cell carcinoma cells
European journal of pharmacology, v 889, pp 173609-173609
15 Dec 2020
PMID: 33031796
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Cancer cells rely heavily on molecular chaperones, such as heat shock protein 90 (HSP90), and their cochaperones. The development of HSP90 inhibitors is an attractive therapeutic approach that has the potential to affect multiple hallmarks of cancer. Such approach is particularly needed for tumors that carry large mutational burdens, including cutaneous squamous cell carcinomas (cSCC). We previously identified sulfoxythiocarbamate S-4 as an HSP90 inhibitor. In this study, we investigated the mechanism(s) by which S-4 compromises the viability of human cSCC cells. S-4 inhibits HSP90 and causes depletion of its clients HER2, a tyrosine kinase oncoprotein, and Bcl-2, an anti-apoptotic protein. The decrease in Bcl-2 is accompanied by cytochrome c release from mitochondria into the cytoplasm, suggesting apoptosis. In the surviving cells, depletion of the HSP90 clients cyclin D and CDK4 by S-4 prevents phosphorylation of the retinoblastoma protein Rb and the release of transcription factor E2F, inhibiting G1-S cell cycle progression and cell division. These findings illustrate the comprehensive effectiveness of S-4 and encourage future development of compounds of this type for cancer prevention and treatment.
Metrics
Details
- Title
- Sulfoxythiocarbamate S-4 inhibits HSP90 in human cutaneous squamous cell carcinoma cells
- Creators
- Ying Zhang - University of DundeeGarrett C. VanHecke - Wayne State UniversityYoung-Hoon Ahn - Wayne State UniversityCharlotte M. Proby - University of DundeeAlbena T. Dinkova-Kostova - Johns Hopkins Medicine
- Publication Details
- European journal of pharmacology, v 889, pp 173609-173609
- Publisher
- Elsevier
- Number of pages
- 9
- Grant note
- C20953/A18644 / Cancer Research UK BB/J007498/1 / Biotechnology and Biological Sciences Research Council (BBSRC); UK Research & Innovation (UKRI) BB/J007498/1 / BBSRC; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC)
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- College of Arts and Sciences; Chemistry; Drexel University
- Web of Science ID
- WOS:000598914700008
- Scopus ID
- 2-s2.0-85092219628
- Other Identifier
- 991020099895904721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Pharmacology & Pharmacy